HC Wainwright Reduces Earnings Estimates for Ekso Bionics

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) – Equities research analysts at HC Wainwright cut their FY2026 earnings per share (EPS) estimates for Ekso Bionics in a research report issued to clients and investors on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings per share of $0.00 for the year, down from their previous estimate of $0.02. HC Wainwright has a “Buy” rating and a $9.00 price objective on the stock. The consensus estimate for Ekso Bionics’ current full-year earnings is ($0.48) per share. HC Wainwright also issued estimates for Ekso Bionics’ FY2027 earnings at $0.12 EPS and FY2029 earnings at $0.46 EPS.

Ekso Bionics (NASDAQ:EKSO) last announced its quarterly earnings data on Monday, March 3rd. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.07). The company had revenue of $5.09 million during the quarter, compared to analysts’ expectations of $5.05 million. Ekso Bionics had a negative net margin of 62.95% and a negative return on equity of 83.09%.

Other equities analysts also recently issued research reports about the stock. StockNews.com began coverage on shares of Ekso Bionics in a report on Monday. They issued a “hold” rating on the stock. Lake Street Capital cut their price objective on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating for the company in a report on Tuesday.

Ekso Bionics Stock Down 1.2 %

Ekso Bionics stock opened at $0.48 on Wednesday. The business’s 50-day simple moving average is $0.61 and its two-hundred day simple moving average is $0.82. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. The company has a market cap of $10.48 million, a PE ratio of -0.73 and a beta of 1.46. Ekso Bionics has a fifty-two week low of $0.37 and a fifty-two week high of $1.78.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.